Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 10:36 PM ET


Company Overview of GlaxoSmithKline Pakistan Ltd.

Company Overview

GlaxoSmithKline Pakistan Limited manufactures and markets research based ethical specialties, other pharmaceutical, and consumer products in Pakistan and internationally. It operates through two segments, Pharmaceuticals and Consumer healthcare. The company deals in anti-infective, respiratory, vaccines, dermatological, analgesics, oncology, urology, central nervous system, allergy, cardiovascular, and vitamins therapy areas. It offers its pharmaceutical products primarily under the Augmentin, Seretide, Amoxil, Velosef, Zantac, and Calpol brands; consumer healthcare products under the Panadol, Horlicks, Sensodyne, and ENO brands; and vaccines under the Synflorix, Infanrix Hexa, Rotarix, Havr...

35, Dockyard Road

West Wharf

Karachi,  74000


2,514 Employees


92 21 111 475 725


92 21 323 14898

Key Executives for GlaxoSmithKline Pakistan Ltd.

GlaxoSmithKline Pakistan Ltd. does not have any Key Executives recorded.

GlaxoSmithKline Pakistan Ltd. Key Developments

GlaxoSmithKline Pakistan Ltd. Reports Earnings Results for the First Half Ended June 30, 2015

GlaxoSmithKline Pakistan Ltd. reported earnings results for the first half ended June 30, 2015. Continuing Operations Profit was PKR 724,028,000 EPS was PKR 2.27 & Discontinuing Operations Profit was PKR 108,861,000 EPS was PKR 0.34.

GlaxoSmithKline Pakistan Ltd. to Report First Half, 2015 Results on Aug 25, 2015

GlaxoSmithKline Pakistan Ltd. announced that they will report first half, 2015 results on Aug 25, 2015

GlaxoSmithKline Pakistan Ltd., Board Meeting, Aug 25, 2015

GlaxoSmithKline Pakistan Ltd., Board Meeting, Aug 25, 2015., at 13:30 Pakistan Standard Time. Agenda: To consider the financial results of the company for the half year ended June 30, 2015.

Similar Private Companies By Industry

Company Name Region
Hilton Pharma (Pvt) Ltd. Middle East/Africa
Biogenist Pharma (Pvt.) Limited Middle East/Africa
GlaxoSmithKline Consumer Healthcare Pakistan Limited Middle East/Africa
OBS Healthcare (Pvt) Ltd. Middle East/Africa
Herbion International, Inc. Middle East/Africa

Recent Private Companies Transactions

August 25, 2015
GlaxoSmithKline Consumer Healthcare Pakistan Limited

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GlaxoSmithKline Pakistan Ltd., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at